ADVANCES IN ANTIBIOTIC THERAPY
1953; American College of Physicians; Volume: 39; Issue: 2 Linguagem: Inglês
10.7326/0003-4819-39-2-307
ISSN1539-3704
Autores Tópico(s)Antimicrobial Resistance in Staphylococcus
ResumoArticle1 August 1953ADVANCES IN ANTIBIOTIC THERAPYJAMES W. HAVILAND, M.D., F.A.C.P.JAMES W. HAVILAND, M.D., F.A.C.P.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-39-2-307 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptAlthough the field of antibiotics is developing so rapidly as to render it almost kaleidoscopic, during recent months several topics of general interest have come into sharp focus. The subject of first consideration will include not only new drugs but also new forms of old drugs, as well as old drugs. Beyond this, I shall confine my discussion to two main items, bacterial resistance to antibiotics, and antibiotic toxicity.NEW ANTIBIOTICS, AND OLDErythromycin (Ilotycin,†Erythrocin,‡) presently holds first place of interest in the evaluation of new antibiotics. Its history is a matter of record.1Although it seems to be...Bibliography1. McGuireBunchAndersonBoazFlynnPowellSmith JMRLRCHEEHHMJW: Ilotycin, a new antibiotic, Antibiotics and Chemotherapy 2: 281, 1952. Google Scholar2. FinlandHaight MTH: Antibiotic resistance of pathogenic staphylococci, Arch. Int. Med. 91: 143, 1953. CrossrefGoogle Scholar3. Kirby WM: Personal communication. Google Scholar4. WelchRandallReedyKramer HWARJJ: Bacterial spectrum of erythromycin, carbomycin, chloramphenicol, aureomycin, and terramycin, Antibiotics and Chemotherapy 2: 693, 1952. Google Scholar5. TannerEnglishLeesRoutien FWARTMJB: Some properties of magnamycin, a new antibiotic, Antibiotics and Chemotherapy 2: 441, 1952. Google Scholar6. EnglishFieldSzendyTaglianiFitts ARMFSRNJRA (a) : Magnamycin. I. In vitro studies, Antibiotics and Chemotherapy 2: 678, 1952. (b) English, A. R., Mullady, H. E., and Fitts, R. A.: Magnamycin. II. In vivo studies, Antibiotics and Chemotherapy 3: 94, 1953. Google Scholar7. TraftonLindCorreia-Branco HMLEM: The treatment of urinary tract infections with a new antibiotic—magnamycin, New England J. Med. 248: 379, 1953. CrossrefMedlineGoogle Scholar8. BarachBickermanBeck ALHAGJ: Antibiotic therapy in infections of the respiratory tract, Arch. Int. Med. 90: 808, 1952. CrossrefGoogle Scholar9. Hallas-MollerJuncherMollerWille KHOCB: Chemical and biological investigations of an organ-specific derivative of penicillin: the hydriodide of the benzyl penicillin—diethyl-aminoethanol ester, Antibiotics and Chemotherapy 2: 334, 1952. Google Scholar10. Report of the Council on Pharmacy and Chemistry: Severe anaphylactoid and fatal reactions to penethamate hydriodide (Neo-Penil), J. A. M. A. 151: 1105, 1953. Google Scholar11. LightTornabenDeBeer AEJAEJ: A comparison of the renal effects of Polymyxin A, Aerosporin, and a mercurial diuretic, Antibiotics and Chemotherapy 2: 63, 1952. Google Scholar12. Jawetz E: Infections with Pseudomonas aeruginosa treated with Polymyxin B, Arch. Int. Med. 89: 90, 1952. CrossrefGoogle Scholar13. DowlingLepper HFMH: Practical problems in the use of antibiotics, M. Clin. North America 36: 247, 1952. CrossrefMedlineGoogle Scholar14. KaganKrevskyMilzerLocke BMDAM: Polymyxin B and Polymyxin E, J. Lab. and Clin. Med. 37: 402, 1951. MedlineGoogle Scholar15. Editorial: Erythromycin, a new broad-spectrum antibiotic, Antibiotics and Chemotherapy 2: 279, 1952. Google Scholar16. Garrod LP: The reactions of bacteria to chemotherapeutic agents, Brit. M. J. 1: 205, 1951. CrossrefMedlineGoogle Scholar17. KochBourgeois MLRW (a) : Report of a further increase in the incidence of drug-resistant pathogenic staphylococci encountered in the hospital laboratory, Antibiotics and Chemotherapy 2: 229, 1952. (b) Prissick, F. H.: Antibiotic-resistant staphylococci and related infections, Am. J. M. Sc. 225: 299, 1953. Google Scholar18. EagleFleischmanLevy HRM: Development of increased bacterial resistance to antibiotics. I. Continuous spectrum of resistance to penicillin, chloramphenicol and streptomycin, J. Bact. 63: 623, 1952. CrossrefMedlineGoogle Scholar19. JawetzGunnison EJB: Studies on antibiotic synergism and antagonism: a scheme of combined antibiotic action, Antibiotics and Chemotherapy 2: 243, 1952. Google Scholar20. Jawetz E: Antibiotic synergism and antagonism, review of experimental evidence, Arch. Int. Med. 90: 301, 1952. CrossrefGoogle Scholar21. RantzRandall LAE: Antibiotic synergism and Staphylococcus aureus , Antibiotics and Chemotherapy 2: 645, 1952. Google Scholar22. LepperDowling MHHF: Treatment of pneumococcic meningitis with penicillin compared with penicillin plus aureomycin: studies including observations on an apparent antagonism between penicillin and aureomycin, Arch. Int. Med. 88: 489, 1951. CrossrefGoogle Scholar23. AhemKirby JJWM: Lack of interference of aureomycin with penicillin in the treatment of pneumococcic pneumonia, Arch. Int. Med. 91: 197, 1953. CrossrefGoogle Scholar24. SmithPerryBerryWood MRWDJWWB: Surface phagocytosis in vivo, J. Immunol. 67: 71, 1951. MedlineGoogle Scholar25. LewisPutnamHendricksKerlanWelch CNLEFDIH: Chloramphenicol (Chloromycetin) in relation to blood dyscrasias with observations on other drugs, Antibiotics and Chemotherapy 2: 601, 1952. Google Scholar26. Unofficial figures furnished through courtesy of Parke, Davis and Co. Google Scholar27. Wintrobe MM: Clinical hematology, 3d Ed., 1951, Lea and Febiger, Philadelphia. Google Scholar28. FinlandWeinstein ML: Complications induced by antimicrobial agents, New England J. Med. 248: 220, 1953. CrossrefMedlineGoogle Scholar29. Hawking F: Toxic and other side effects of antibiotics, Medicine Illus. (London) 6: 278, 1952. MedlineGoogle Scholar30. Tomaszewski T: Side effects of chloramphenicol and aureomycin, with special reference to oral lesions, Brit. M. J. 1: 388, 1951. CrossrefMedlineGoogle Scholar31. MayerMoskoSchutzOstermanSteenBaker PSMMPJFALHLA: Penicillin anaphylaxis, J. A. M. A. 151: 351, 1953. MedlineGoogle Scholar32. DykeWallace VFJB: Development of aplastic anemia during the use of streptomycin, J. A. M. A. 136: 1098, 1948. CrossrefMedlineGoogle Scholar33. RutenburgPinkes AMS: The hepatotoxicity of intravenous aureomycin, New England J. Med. 247: 797, 1952. CrossrefMedlineGoogle Scholar34. BatemanBarberioCromerKlobb JCJRJKCT: Investigation of mechanism and type of jaundice produced by large doses of parenterally-administered aureomycin, Antibiotics and Chemotherapy 3: 1, 1953. Google Scholar35. KutscherLane AHSL: The clinical toxicity of antibacterial drugs, Oral Surg., Oral Med. and Oral Path. 5: 347, 1952. CrossrefMedlineGoogle Scholar36. Smith DT: The disturbance of normal bacterial ecology by administration of antibiotics with the development of new clinical syndromes, Ann. Int. Med. 37: 1135, 1952. LinkGoogle Scholar37. DowlingLepperJackson HFMHGG: When should antibiotics be used in combination? J. A. M. A. 151: 813, 1953. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Seattle, Washington*Presented at the Thirty-Fourth Annual Session of the American College of Physicians, Atlantic City, New Jersey, April 15, 1953.From the Department of Medicine, University of Washington School of Medicine, and King County Hospital, Seattle, Washington.†Trademark, registered, Eli Lilly and Co.†Trademark, registered, Abbott Laboratories. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byANTIBIOTIC-RESISTANT BACTERIAResponse of the Human Gastrointestinal Tract to ErythromycinErythromycin enhances delayed gastric emptying in dogs after Roux-Y antrectomyErythromycinChemotherapie und antibiotische Therapie der Gonorrhoe. Allgemeine GrundlagenErythromycinDie AntibioticaTHE PARTICIPATION OF POLYMYXIN B IN COMBINED ANTIBIOTIC ACTION*ERNEST JAWETZ, M.D., Ph.D., VIRGINIA COLEMAN, B.A., JANET B. GUNNISON, M.A. 1 August 1953Volume 39, Issue 2Page: 307-317KeywordsAntibiotic resistanceAntibioticsDrugsErythromycinHospital medicineToxicity ePublished: 1 December 2008 Issue Published: 1 August 1953 PDF downloadLoading ...
Referência(s)